Phase 1 Trial Combining Neoadjuvant Chemotherapy with Chemokine Modulatory Regimen for Triple Negative Breast Cancer
Ontology highlight
ABSTRACT: Phase 1 Trial Combining Neoadjuvant Chemotherapy with Chemokine Modulatory Regimen for Triple Negative Breast Cancer
PROVIDER: PRJNA1084787 | ENA |
REPOSITORIES: ENA
ACCESS DATA